Nasdaq-listed industry technology group Scientific Games Corporation (SGC), has expanded its governance committee, confirming the appointment of Kneeland C. Youngblood as a new company director.
An expert in large-scale financing projects, corporate recapitalisation and political stakeholder management, Youngblood will serve as an SGC advisor and member of the Nasdaq enterprises’ compensation and compliance committees.
A qualified physician, Youngblood is the founding partner of US healthcare and pharmaceutical private equity firm Pharos Capital LLC.
A Texas native Youngblood also serves as director of Mallinckrodt plc, a speciality pharmaceutical company, and as a director of TPG Pace Holdings. Furthermore, Youngblood has served as a member of the US Council of Foreign Relations.
“We are pleased that the Board elected Kneeland as a new director,” said Barry Cottle, Group Chief Executive officer of Scientific Games.
“He brings valuable experience in business, operations and strategy to our team. We look forward to Kneeland’s contributions as we continue to drive growth in our core business and take advantage of new opportunities to engage players and bring value to our customers.”